Bostwick Laboratories

Representation of the creditors’ committee in the chapter 11 case of cancer testing firm Bostwick Laboratories in the District of Delaware. The company filed for bankruptcy protection after the lab was impacted by a decline in medical insurance reimbursements that started in 2012. In April 2017, the debtor moved forward with an auction and sale process for its assets after securing approval for its $6,300,000 stalking horse agreement.